Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
by
Ling Xiao
, Aifeng Zhang
, Katherine Hessler
, Shiro Baba
, Saumya Das
, Santosh Khedkar
, Alan C. Rigby
, Bridget Simonson
, Filomena G. Ottaviano
, Anthony Rosenzweig
, David J. Milan
, Stacey N. Lynch
, Vassilios J. Bezzerides
in
119/118
/ 631/154
/ 64/116
/ 692/4019
/ 82/1
/ 9/74
/ Animals
/ Arrhythmias, Cardiac
/ Arrhythmias, Cardiac - therapy
/ Cells, Cultured
/ Disease Models, Animal
/ Humanities and Social Sciences
/ Humans
/ Immediate-Early Proteins
/ Immediate-Early Proteins - genetics
/ Immediate-Early Proteins - metabolism
/ Medicine
/ multidisciplinary
/ Myocytes, Cardiac
/ Myocytes, Cardiac - drug effects
/ Myocytes, Cardiac - physiology
/ NAV1.5 Voltage-Gated Sodium Channel
/ NAV1.5 Voltage-Gated Sodium Channel - metabolism
/ Protein Interaction Mapping
/ Protein Kinase Inhibitors
/ Protein Kinase Inhibitors - isolation & purification
/ Protein Kinase Inhibitors - pharmacology
/ Protein Serine-Threonine Kinases
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Q
/ R
/ Science
/ Science (multidisciplinary)
/ Zebrafish
2017
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
by
Ling Xiao
, Aifeng Zhang
, Katherine Hessler
, Shiro Baba
, Saumya Das
, Santosh Khedkar
, Alan C. Rigby
, Bridget Simonson
, Filomena G. Ottaviano
, Anthony Rosenzweig
, David J. Milan
, Stacey N. Lynch
, Vassilios J. Bezzerides
in
119/118
/ 631/154
/ 64/116
/ 692/4019
/ 82/1
/ 9/74
/ Animals
/ Arrhythmias, Cardiac
/ Arrhythmias, Cardiac - therapy
/ Cells, Cultured
/ Disease Models, Animal
/ Humanities and Social Sciences
/ Humans
/ Immediate-Early Proteins
/ Immediate-Early Proteins - genetics
/ Immediate-Early Proteins - metabolism
/ Medicine
/ multidisciplinary
/ Myocytes, Cardiac
/ Myocytes, Cardiac - drug effects
/ Myocytes, Cardiac - physiology
/ NAV1.5 Voltage-Gated Sodium Channel
/ NAV1.5 Voltage-Gated Sodium Channel - metabolism
/ Protein Interaction Mapping
/ Protein Kinase Inhibitors
/ Protein Kinase Inhibitors - isolation & purification
/ Protein Kinase Inhibitors - pharmacology
/ Protein Serine-Threonine Kinases
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Q
/ R
/ Science
/ Science (multidisciplinary)
/ Zebrafish
2017
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
by
Ling Xiao
, Aifeng Zhang
, Katherine Hessler
, Shiro Baba
, Saumya Das
, Santosh Khedkar
, Alan C. Rigby
, Bridget Simonson
, Filomena G. Ottaviano
, Anthony Rosenzweig
, David J. Milan
, Stacey N. Lynch
, Vassilios J. Bezzerides
in
119/118
/ 631/154
/ 64/116
/ 692/4019
/ 82/1
/ 9/74
/ Animals
/ Arrhythmias, Cardiac
/ Arrhythmias, Cardiac - therapy
/ Cells, Cultured
/ Disease Models, Animal
/ Humanities and Social Sciences
/ Humans
/ Immediate-Early Proteins
/ Immediate-Early Proteins - genetics
/ Immediate-Early Proteins - metabolism
/ Medicine
/ multidisciplinary
/ Myocytes, Cardiac
/ Myocytes, Cardiac - drug effects
/ Myocytes, Cardiac - physiology
/ NAV1.5 Voltage-Gated Sodium Channel
/ NAV1.5 Voltage-Gated Sodium Channel - metabolism
/ Protein Interaction Mapping
/ Protein Kinase Inhibitors
/ Protein Kinase Inhibitors - isolation & purification
/ Protein Kinase Inhibitors - pharmacology
/ Protein Serine-Threonine Kinases
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Q
/ R
/ Science
/ Science (multidisciplinary)
/ Zebrafish
2017
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
Journal Article
Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders
2017
Request Book From Autostore
and Choose the Collection Method
Overview
Alterations in sodium flux (I
Na
) play an important role in the pathogenesis of cardiac arrhythmias and may also contribute to the development of cardiomyopathies. We have recently demonstrated a critical role for the regulation of the voltage-gated sodium channel Na
V
1.5 in the heart by the serum and glucocorticoid regulated kinase-1 (SGK1). Activation of SGK1 in the heart causes a marked increase in both the peak and late sodium currents leading to prolongation of the action potential duration and an increased propensity to arrhythmia. Here we show that SGK1 directly regulates Na
V
1.5 channel function, and genetic inhibition of SGK1 in a zebrafish model of inherited long QT syndrome rescues the long QT phenotype. Using computer-aided drug discovery coupled with
in vitro
kinase assays, we identified a novel class of SGK1 inhibitors. Our lead SGK1 inhibitor (5377051) selectively inhibits SGK1 in cultured cardiomyocytes, and inhibits phosphorylation of an SGK1-specific target as well as proliferation in the prostate cancer cell line, LNCaP. Finally, 5377051 can reverse SGK1’s effects on Na
V
1.5 and shorten the action potential duration in induced pluripotent stem cell (iPSC)-derived cardiomyocytes from a patient with a gain-of-function mutation in Nav 1.5 (Long QT3 syndrome). Our data suggests that SGK1 inhibitors warrant further investigation in the treatment of cardiac arrhythmias.
Publisher
Springer Science and Business Media LLC,Nature Publishing Group UK,Nature Portfolio
Subject
/ 631/154
/ 64/116
/ 692/4019
/ 82/1
/ 9/74
/ Animals
/ Arrhythmias, Cardiac - therapy
/ Humanities and Social Sciences
/ Humans
/ Immediate-Early Proteins - genetics
/ Immediate-Early Proteins - metabolism
/ Medicine
/ Myocytes, Cardiac - drug effects
/ Myocytes, Cardiac - physiology
/ NAV1.5 Voltage-Gated Sodium Channel
/ NAV1.5 Voltage-Gated Sodium Channel - metabolism
/ Protein Kinase Inhibitors - isolation & purification
/ Protein Kinase Inhibitors - pharmacology
/ Protein Serine-Threonine Kinases
/ Protein Serine-Threonine Kinases - genetics
/ Protein Serine-Threonine Kinases - metabolism
/ Q
/ R
/ Science
This website uses cookies to ensure you get the best experience on our website.